Investment Insights
We partner with Hedge Funds, Private Equity houses, Venture Capital firms, Private / Angel investors, startups and entrepreneurs, providing timely and actionable research and insights that yield a competitive advantage.
From uncovering hidden investment opportunities and identifying emerging investment trends, to supporting a due-diligence process with crucial intelligence, we can provide timely and insightful recommendations for our clients.
Our insights and advisory focus on:
- Landscape analysis, including scientific and commercial due diligence
- Company / asset profiling, including addressable market size, growth drivers and expected growth, segmentation, value proposition etc.
- Decision-making opportunity / risk assessment, both for investors and their portfolio companies
- Other research and advisory, customized to our clients’ needs
We also provide fundraising services, by connecting entrepreneurs and companies who seek the all-important capital to kick-start or grow their venture with potential investors from our extensive network of contacts.
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, related to trending news from the investment space.
Want to make informed investments and capitalize on key opportunities? Let’s connect!
Reach out to info@lqventures.com to learn more about our strategic consulting and research capabilities.
October 29, 2025
Lucid Diligence Brief: GSK licenses Empirico’s siRNA in COPD
October 28, 2025
Lucid Diligence Brief: GSK and Syndivia preclinical ADC in mCRPC
October 28, 2025
Endocrinology Today — October 28, 2025
October 28, 2025
Obesity Today — October 28, 2025
October 28, 2025
Lucid Diligence Brief: Guardant Health and Zephyr AI partnership
October 28, 2025
Obesity Video Recap — October 28, 2025
October 27, 2025
Hematology Today — October 27, 2025
October 27, 2025
Oncology Video Recap — October 27, 2025
October 27, 2025
Oncology Today — October 27, 2025
October 27, 2025
AI in Healthcare and Digital Health Today—October 27, 2025
October 27, 2025
Lucid Diligence Brief: Novartis to acquire Avidity Biosciences
October 26, 2025